Review



d609  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    MedChemExpress d609
    Increased sEV secretion in cholesterol‐depleted conditions is due to autophagy‐driven signalling. (A) Representative images for CD63 and LC3B expression in HEK293T or HEK293T ATG2A/B KO cells after vehicle, AY9944 or rapamycin and chloroquine (Rap & CQN) treatment. Scale bar, 25 µm. (B) Quantified CD63 expression in HEK293T and HEK293T ATG2A/B KO cells (mean ± SEM; n = 8 images analyzed from 2 independent experiments). Two‐way ANOVA (treatment effect: F2,42 = 47.99, p < 0.0001; Autophagy effect: F1,42 = 5.422, p ≤ 0.0248). Sidak's multiple comparisons test (** p ≤ 0.005, **** p < 0.0001). (C) LC3B expression in HEK293T and HEK293T ATG2A/B KO cells (mean ± SEM; n = 8, 4 images analyzed from 2 independent experiments). Two‐way ANOVA (interaction effect: F2,42 = 6.126, p ≤ 0.0046; treatment effect: F2,42 = 5.995, p ≤ 0.0051; Autophagy effect: F1,42 = 12.65, p ≤ 0.0009). Sidak's multiple comparisons test (* p ≤ 0.05, ** p ≤ 0.005, *** p ≤ 0.001). (D) Immunoblot for LC3B in isolated sEVs upon cholesterol depletion. (E) CD63 and LC3B colocalization in HEK293T and HEK293T ATG2A/B KO cells (mean ± SEM; n = 8 images analyzed from 2 independent experiments). Two‐way ANOVA (interaction effect: F2,53 = 128.9, p < 0.0001; treatment effect: F2,53 = 157.0, p < 0.0001; autophagy effect: F1,53 = 453.1, p < 0.0001). Sidak's multiple comparisons test (**** p < 0.0001). (F) Quantified sEV secretion in HEK293T or HEK293T ATG2A/B KO cells following vehicle, AY9944, or Rap & CQN treatments (mean ± SEM; n = 3 biological replicates from 3 independent experiments). One‐way ANOVA (F2,6 = 56.17, p ≤ 0.0001), Dunnett's multiple comparisons test (** p ≤ 0.01, **** p < 0.0001). (G) sEV secretion in HEK293T or HEK293T ATG2A/B KO cells following vehicle or <t>D609</t> treatments (mean ± SEM; n = 3 biological replicates from 3 independent experiments). Unpaired t‐test (HEK293T: t4 = 9.395, *** p ≤ 0.0007; HEK293T ATG2A/B KO: t 4 = 4.069, ** p ≤ 0.0152).
    D609, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 17 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/d609/product/MedChemExpress
    Average 94 stars, based on 17 article reviews
    d609 - by Bioz Stars, 2026-02
    94/100 stars

    Images

    1) Product Images from "Cholesterol Deficiency Directs Autophagy‐Dependent Secretion of Extracellular Vesicles"

    Article Title: Cholesterol Deficiency Directs Autophagy‐Dependent Secretion of Extracellular Vesicles

    Journal: Journal of Extracellular Vesicles

    doi: 10.1002/jev2.70218

    Increased sEV secretion in cholesterol‐depleted conditions is due to autophagy‐driven signalling. (A) Representative images for CD63 and LC3B expression in HEK293T or HEK293T ATG2A/B KO cells after vehicle, AY9944 or rapamycin and chloroquine (Rap & CQN) treatment. Scale bar, 25 µm. (B) Quantified CD63 expression in HEK293T and HEK293T ATG2A/B KO cells (mean ± SEM; n = 8 images analyzed from 2 independent experiments). Two‐way ANOVA (treatment effect: F2,42 = 47.99, p < 0.0001; Autophagy effect: F1,42 = 5.422, p ≤ 0.0248). Sidak's multiple comparisons test (** p ≤ 0.005, **** p < 0.0001). (C) LC3B expression in HEK293T and HEK293T ATG2A/B KO cells (mean ± SEM; n = 8, 4 images analyzed from 2 independent experiments). Two‐way ANOVA (interaction effect: F2,42 = 6.126, p ≤ 0.0046; treatment effect: F2,42 = 5.995, p ≤ 0.0051; Autophagy effect: F1,42 = 12.65, p ≤ 0.0009). Sidak's multiple comparisons test (* p ≤ 0.05, ** p ≤ 0.005, *** p ≤ 0.001). (D) Immunoblot for LC3B in isolated sEVs upon cholesterol depletion. (E) CD63 and LC3B colocalization in HEK293T and HEK293T ATG2A/B KO cells (mean ± SEM; n = 8 images analyzed from 2 independent experiments). Two‐way ANOVA (interaction effect: F2,53 = 128.9, p < 0.0001; treatment effect: F2,53 = 157.0, p < 0.0001; autophagy effect: F1,53 = 453.1, p < 0.0001). Sidak's multiple comparisons test (**** p < 0.0001). (F) Quantified sEV secretion in HEK293T or HEK293T ATG2A/B KO cells following vehicle, AY9944, or Rap & CQN treatments (mean ± SEM; n = 3 biological replicates from 3 independent experiments). One‐way ANOVA (F2,6 = 56.17, p ≤ 0.0001), Dunnett's multiple comparisons test (** p ≤ 0.01, **** p < 0.0001). (G) sEV secretion in HEK293T or HEK293T ATG2A/B KO cells following vehicle or D609 treatments (mean ± SEM; n = 3 biological replicates from 3 independent experiments). Unpaired t‐test (HEK293T: t4 = 9.395, *** p ≤ 0.0007; HEK293T ATG2A/B KO: t 4 = 4.069, ** p ≤ 0.0152).
    Figure Legend Snippet: Increased sEV secretion in cholesterol‐depleted conditions is due to autophagy‐driven signalling. (A) Representative images for CD63 and LC3B expression in HEK293T or HEK293T ATG2A/B KO cells after vehicle, AY9944 or rapamycin and chloroquine (Rap & CQN) treatment. Scale bar, 25 µm. (B) Quantified CD63 expression in HEK293T and HEK293T ATG2A/B KO cells (mean ± SEM; n = 8 images analyzed from 2 independent experiments). Two‐way ANOVA (treatment effect: F2,42 = 47.99, p < 0.0001; Autophagy effect: F1,42 = 5.422, p ≤ 0.0248). Sidak's multiple comparisons test (** p ≤ 0.005, **** p < 0.0001). (C) LC3B expression in HEK293T and HEK293T ATG2A/B KO cells (mean ± SEM; n = 8, 4 images analyzed from 2 independent experiments). Two‐way ANOVA (interaction effect: F2,42 = 6.126, p ≤ 0.0046; treatment effect: F2,42 = 5.995, p ≤ 0.0051; Autophagy effect: F1,42 = 12.65, p ≤ 0.0009). Sidak's multiple comparisons test (* p ≤ 0.05, ** p ≤ 0.005, *** p ≤ 0.001). (D) Immunoblot for LC3B in isolated sEVs upon cholesterol depletion. (E) CD63 and LC3B colocalization in HEK293T and HEK293T ATG2A/B KO cells (mean ± SEM; n = 8 images analyzed from 2 independent experiments). Two‐way ANOVA (interaction effect: F2,53 = 128.9, p < 0.0001; treatment effect: F2,53 = 157.0, p < 0.0001; autophagy effect: F1,53 = 453.1, p < 0.0001). Sidak's multiple comparisons test (**** p < 0.0001). (F) Quantified sEV secretion in HEK293T or HEK293T ATG2A/B KO cells following vehicle, AY9944, or Rap & CQN treatments (mean ± SEM; n = 3 biological replicates from 3 independent experiments). One‐way ANOVA (F2,6 = 56.17, p ≤ 0.0001), Dunnett's multiple comparisons test (** p ≤ 0.01, **** p < 0.0001). (G) sEV secretion in HEK293T or HEK293T ATG2A/B KO cells following vehicle or D609 treatments (mean ± SEM; n = 3 biological replicates from 3 independent experiments). Unpaired t‐test (HEK293T: t4 = 9.395, *** p ≤ 0.0007; HEK293T ATG2A/B KO: t 4 = 4.069, ** p ≤ 0.0152).

    Techniques Used: Expressing, Western Blot, Isolation



    Similar Products

    95
    Developmental Studies Hybridoma Bank anti-chat
    Anti Chat, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-chat/product/Developmental Studies Hybridoma Bank
    Average 95 stars, based on 1 article reviews
    anti-chat - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    96
    Thermo Fisher alexa fluor 488 goat anti mouse antibody
    Alexa Fluor 488 Goat Anti Mouse Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/alexa fluor 488 goat anti mouse antibody/product/Thermo Fisher
    Average 96 stars, based on 1 article reviews
    alexa fluor 488 goat anti mouse antibody - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    Thermo Fisher goat anti mouse alexa fluor 488
    Goat Anti Mouse Alexa Fluor 488, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat anti mouse alexa fluor 488/product/Thermo Fisher
    Average 96 stars, based on 1 article reviews
    goat anti mouse alexa fluor 488 - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    Thermo Fisher alexafluor 488
    Alexafluor 488, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/alexafluor 488/product/Thermo Fisher
    Average 96 stars, based on 1 article reviews
    alexafluor 488 - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    Thermo Fisher alexafluor 488 α mouse igg
    Alexafluor 488 α Mouse Igg, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/alexafluor 488 α mouse igg/product/Thermo Fisher
    Average 96 stars, based on 1 article reviews
    alexafluor 488 α mouse igg - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    Thermo Fisher antibody goat anti mouse alexa fluortm 488
    Antibody Goat Anti Mouse Alexa Fluortm 488, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibody goat anti mouse alexa fluortm 488/product/Thermo Fisher
    Average 96 stars, based on 1 article reviews
    antibody goat anti mouse alexa fluortm 488 - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    Thermo Fisher a11029
    A11029, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/a11029/product/Thermo Fisher
    Average 96 stars, based on 1 article reviews
    a11029 - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    Thermo Fisher goat anti mouse
    Contribution of CD8 + T-cells to control of JEV infection. (A) Schematic representation of experimental plans for CD8 depletion. IP injection <t>of</t> <t>anti-mouse</t> CD8α and Isotype (150 µg/mouse) was given before 48 h of JEV-S1 infection, and antibodies were given as depicted in the schematic figure. (B) Contour plots represent the percentage of CD4 and CD8+ cells. Lymphocyte cell counts (n=4 in each group) in peripheral blood at day 0 and day 6, depicted as a bar graph. P -values are calculated using an unpaired Student’s t-test; ***P<0.001. (C) Kaplan-Meier survival curve of isotype and anti-CD8α-JEV-S1 infected mice (n=7 in each group). (D) The change in the body weight of CD8 + T-cells depleted of JEV-S1 and isotype-infected mice. (E) The Clinical Score is shown in the CD8 + T-cells-depleted group and isotype-infected mice. The color represents a score (0–5) related to the clinical symptoms; ‘0’ represents no symptoms, and 5 represents the most severe symptoms. (F) The expression levels of NS3 and GAPDH were detected in the infected mice brains by immunoblotting.
    Goat Anti Mouse, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat anti mouse/product/Thermo Fisher
    Average 96 stars, based on 1 article reviews
    goat anti mouse - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    Thermo Fisher alexa fluor 488 goat anti mouse igg
    Effect of LOCBE, rLOPAP, and rLOSAC on Rac-1 and F-actin. Chondrocytes (8 × 10 3 cells/well in 96-well plate) cultured in DMEM-F12 medium containing 1% FBS were treated or not with 1 ng/mL IL-1β for 1 h, followed by the addition of 50 µg/mL LOCBE, 200 nM rLOSAC, or 200 nM rLOPAP and incubation for 24 h. Cells were fixed and immunolabeled with a primary antibody against Rac-1 and an Alexa Fluor-647-conjugated secondary antibody (red) with nuclear counterstaining by Hoechst 33342 (blue) and F-actin staining by Alexa Fluor 488-phalloidin (green). The stained samples were analyzed by HCS (20× magnification) for quantification of Rac-1 ( A ) and F-actin ( B ). Data represent the mean ± SD from 16 different fields per well. # p > 0.05, * p > 0.05, ** p > 0.01, **** p > 0.0001 (unpaired Student’s t -test, n = 9 independent replicates). CTRL, chondrocytes cultivated in basal DMEM-F12 medium containing 1% FBS (dotted line as a reference). Representative images of F-actin (green), Rac-1 (red), and nuclei (blue) under basal ( C ) or inflammatory conditions ( D ). Control: untreated chondrocytes. The white arrow in the “IL-1β” panel highlights retracted and rounded cells, with yellow color indicating co-localization of Rac-1 and F-actin, an effect that was reduced in the presence of rLOPAP. Scale bar 100 μm.
    Alexa Fluor 488 Goat Anti Mouse Igg, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/alexa fluor 488 goat anti mouse igg/product/Thermo Fisher
    Average 96 stars, based on 1 article reviews
    alexa fluor 488 goat anti mouse igg - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    94
    MedChemExpress d609
    Increased sEV secretion in cholesterol‐depleted conditions is due to autophagy‐driven signalling. (A) Representative images for CD63 and LC3B expression in HEK293T or HEK293T ATG2A/B KO cells after vehicle, AY9944 or rapamycin and chloroquine (Rap & CQN) treatment. Scale bar, 25 µm. (B) Quantified CD63 expression in HEK293T and HEK293T ATG2A/B KO cells (mean ± SEM; n = 8 images analyzed from 2 independent experiments). Two‐way ANOVA (treatment effect: F2,42 = 47.99, p < 0.0001; Autophagy effect: F1,42 = 5.422, p ≤ 0.0248). Sidak's multiple comparisons test (** p ≤ 0.005, **** p < 0.0001). (C) LC3B expression in HEK293T and HEK293T ATG2A/B KO cells (mean ± SEM; n = 8, 4 images analyzed from 2 independent experiments). Two‐way ANOVA (interaction effect: F2,42 = 6.126, p ≤ 0.0046; treatment effect: F2,42 = 5.995, p ≤ 0.0051; Autophagy effect: F1,42 = 12.65, p ≤ 0.0009). Sidak's multiple comparisons test (* p ≤ 0.05, ** p ≤ 0.005, *** p ≤ 0.001). (D) Immunoblot for LC3B in isolated sEVs upon cholesterol depletion. (E) CD63 and LC3B colocalization in HEK293T and HEK293T ATG2A/B KO cells (mean ± SEM; n = 8 images analyzed from 2 independent experiments). Two‐way ANOVA (interaction effect: F2,53 = 128.9, p < 0.0001; treatment effect: F2,53 = 157.0, p < 0.0001; autophagy effect: F1,53 = 453.1, p < 0.0001). Sidak's multiple comparisons test (**** p < 0.0001). (F) Quantified sEV secretion in HEK293T or HEK293T ATG2A/B KO cells following vehicle, AY9944, or Rap & CQN treatments (mean ± SEM; n = 3 biological replicates from 3 independent experiments). One‐way ANOVA (F2,6 = 56.17, p ≤ 0.0001), Dunnett's multiple comparisons test (** p ≤ 0.01, **** p < 0.0001). (G) sEV secretion in HEK293T or HEK293T ATG2A/B KO cells following vehicle or <t>D609</t> treatments (mean ± SEM; n = 3 biological replicates from 3 independent experiments). Unpaired t‐test (HEK293T: t4 = 9.395, *** p ≤ 0.0007; HEK293T ATG2A/B KO: t 4 = 4.069, ** p ≤ 0.0152).
    D609, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/d609/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    d609 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    Image Search Results


    Contribution of CD8 + T-cells to control of JEV infection. (A) Schematic representation of experimental plans for CD8 depletion. IP injection of anti-mouse CD8α and Isotype (150 µg/mouse) was given before 48 h of JEV-S1 infection, and antibodies were given as depicted in the schematic figure. (B) Contour plots represent the percentage of CD4 and CD8+ cells. Lymphocyte cell counts (n=4 in each group) in peripheral blood at day 0 and day 6, depicted as a bar graph. P -values are calculated using an unpaired Student’s t-test; ***P<0.001. (C) Kaplan-Meier survival curve of isotype and anti-CD8α-JEV-S1 infected mice (n=7 in each group). (D) The change in the body weight of CD8 + T-cells depleted of JEV-S1 and isotype-infected mice. (E) The Clinical Score is shown in the CD8 + T-cells-depleted group and isotype-infected mice. The color represents a score (0–5) related to the clinical symptoms; ‘0’ represents no symptoms, and 5 represents the most severe symptoms. (F) The expression levels of NS3 and GAPDH were detected in the infected mice brains by immunoblotting.

    Journal: Frontiers in Immunology

    Article Title: Neutrophil depletion at the early stage of Japanese encephalitis virus infection affects CD8+ T cell infiltration into the mouse brain and causes severe encephalitis

    doi: 10.3389/fimmu.2025.1748085

    Figure Lengend Snippet: Contribution of CD8 + T-cells to control of JEV infection. (A) Schematic representation of experimental plans for CD8 depletion. IP injection of anti-mouse CD8α and Isotype (150 µg/mouse) was given before 48 h of JEV-S1 infection, and antibodies were given as depicted in the schematic figure. (B) Contour plots represent the percentage of CD4 and CD8+ cells. Lymphocyte cell counts (n=4 in each group) in peripheral blood at day 0 and day 6, depicted as a bar graph. P -values are calculated using an unpaired Student’s t-test; ***P<0.001. (C) Kaplan-Meier survival curve of isotype and anti-CD8α-JEV-S1 infected mice (n=7 in each group). (D) The change in the body weight of CD8 + T-cells depleted of JEV-S1 and isotype-infected mice. (E) The Clinical Score is shown in the CD8 + T-cells-depleted group and isotype-infected mice. The color represents a score (0–5) related to the clinical symptoms; ‘0’ represents no symptoms, and 5 represents the most severe symptoms. (F) The expression levels of NS3 and GAPDH were detected in the infected mice brains by immunoblotting.

    Article Snippet: Cells were washed multiple times with PBS, Alexa Fluor 488, goat anti-mouse (1:600) (A11029; Invitrogen, Carlsbad, CA, USA) was added for one h at RT, Following multiple wash with 1X PBS, Coverslips were then mounted, and the nucleus was stained with 4′,6-diamidine-2′- pheynylindole dihydrochloride (DAPI) (D1306; Invitrogen, Carlsbad, CA, USA).

    Techniques: Control, Infection, Injection, Expressing, Western Blot

    Effect of LOCBE, rLOPAP, and rLOSAC on Rac-1 and F-actin. Chondrocytes (8 × 10 3 cells/well in 96-well plate) cultured in DMEM-F12 medium containing 1% FBS were treated or not with 1 ng/mL IL-1β for 1 h, followed by the addition of 50 µg/mL LOCBE, 200 nM rLOSAC, or 200 nM rLOPAP and incubation for 24 h. Cells were fixed and immunolabeled with a primary antibody against Rac-1 and an Alexa Fluor-647-conjugated secondary antibody (red) with nuclear counterstaining by Hoechst 33342 (blue) and F-actin staining by Alexa Fluor 488-phalloidin (green). The stained samples were analyzed by HCS (20× magnification) for quantification of Rac-1 ( A ) and F-actin ( B ). Data represent the mean ± SD from 16 different fields per well. # p > 0.05, * p > 0.05, ** p > 0.01, **** p > 0.0001 (unpaired Student’s t -test, n = 9 independent replicates). CTRL, chondrocytes cultivated in basal DMEM-F12 medium containing 1% FBS (dotted line as a reference). Representative images of F-actin (green), Rac-1 (red), and nuclei (blue) under basal ( C ) or inflammatory conditions ( D ). Control: untreated chondrocytes. The white arrow in the “IL-1β” panel highlights retracted and rounded cells, with yellow color indicating co-localization of Rac-1 and F-actin, an effect that was reduced in the presence of rLOPAP. Scale bar 100 μm.

    Journal: International Journal of Molecular Sciences

    Article Title: Venom-Derived Proteins from Lonomia obliqua Modulate Cytoskeletal Regulators and Inflammatory Responses in Human Chondrocytes

    doi: 10.3390/ijms27020934

    Figure Lengend Snippet: Effect of LOCBE, rLOPAP, and rLOSAC on Rac-1 and F-actin. Chondrocytes (8 × 10 3 cells/well in 96-well plate) cultured in DMEM-F12 medium containing 1% FBS were treated or not with 1 ng/mL IL-1β for 1 h, followed by the addition of 50 µg/mL LOCBE, 200 nM rLOSAC, or 200 nM rLOPAP and incubation for 24 h. Cells were fixed and immunolabeled with a primary antibody against Rac-1 and an Alexa Fluor-647-conjugated secondary antibody (red) with nuclear counterstaining by Hoechst 33342 (blue) and F-actin staining by Alexa Fluor 488-phalloidin (green). The stained samples were analyzed by HCS (20× magnification) for quantification of Rac-1 ( A ) and F-actin ( B ). Data represent the mean ± SD from 16 different fields per well. # p > 0.05, * p > 0.05, ** p > 0.01, **** p > 0.0001 (unpaired Student’s t -test, n = 9 independent replicates). CTRL, chondrocytes cultivated in basal DMEM-F12 medium containing 1% FBS (dotted line as a reference). Representative images of F-actin (green), Rac-1 (red), and nuclei (blue) under basal ( C ) or inflammatory conditions ( D ). Control: untreated chondrocytes. The white arrow in the “IL-1β” panel highlights retracted and rounded cells, with yellow color indicating co-localization of Rac-1 and F-actin, an effect that was reduced in the presence of rLOPAP. Scale bar 100 μm.

    Article Snippet: After three washes with PHEM-glycine buffer (PHEM containing 100 mM glycine), nuclei were stained with Hoechst 33342 (1/1000, Invitrogen #H3570) and secondary antibodies: Alexa Fluor 488 goat anti-mouse IgG (1:1000, Invitrogen #A11029, Carlsbad, CA, USA) or Alexa Fluor 647 goat anti-rabbit IgG (1:1000, Invitrogen #A21244, Carlsbad, CA, USA) for 1 h at room temperature.

    Techniques: Cell Culture, Incubation, Immunolabeling, Staining, Control

    Effect of LOCBE, rLOPAP, and rLOSAC on RhoA. Chondrocytes (8 × 10 3 cells/well in 96-well plate) cultured in DMEM-F12 medium containing 1% FBS were treated or not with 1 ng/mL IL-1β for 1 h, followed by the addition of 50 µg/mL LOCBE, 200 nM rLOSAC, or 200 nM rLOPAP and incubation for 24 h. Cells were fixed and immunolabeled with a primary antibody against RhoA and an Alexa Fluor-488-conjugated secondary antibody (green), with nuclear counterstaining by Hoechst 33342 (blue). The stained samples were analyzed by HCS (20× magnification), and fluorescence intensities were quantified in nuclear and cytoplasmic compartments under normal ( A , C ) and inflammatory ( B , D ) conditions. Data represent the mean ± SD from 16 different fields per well. * p > 0.05, *** p > 0.001 (unpaired Student’s t -test, n = 6 independent replicates). CTRL, chondrocytes cultivated in basal DMEM-F12 medium containing 1% FBS. Representative images of RhoA (green) and nuclei (blue) of chondrocytes under basal ( C ) or inflammatory conditions ( D ). Control: untreated chondrocytes. Zoomed-in panels highlight the more intense RhoA staining in the cytoplasm. The white arrow in the “IL-1β” zoomed-in panel indicates the presence of RhoA in the cytoplasm. Scale bar 100 μm.

    Journal: International Journal of Molecular Sciences

    Article Title: Venom-Derived Proteins from Lonomia obliqua Modulate Cytoskeletal Regulators and Inflammatory Responses in Human Chondrocytes

    doi: 10.3390/ijms27020934

    Figure Lengend Snippet: Effect of LOCBE, rLOPAP, and rLOSAC on RhoA. Chondrocytes (8 × 10 3 cells/well in 96-well plate) cultured in DMEM-F12 medium containing 1% FBS were treated or not with 1 ng/mL IL-1β for 1 h, followed by the addition of 50 µg/mL LOCBE, 200 nM rLOSAC, or 200 nM rLOPAP and incubation for 24 h. Cells were fixed and immunolabeled with a primary antibody against RhoA and an Alexa Fluor-488-conjugated secondary antibody (green), with nuclear counterstaining by Hoechst 33342 (blue). The stained samples were analyzed by HCS (20× magnification), and fluorescence intensities were quantified in nuclear and cytoplasmic compartments under normal ( A , C ) and inflammatory ( B , D ) conditions. Data represent the mean ± SD from 16 different fields per well. * p > 0.05, *** p > 0.001 (unpaired Student’s t -test, n = 6 independent replicates). CTRL, chondrocytes cultivated in basal DMEM-F12 medium containing 1% FBS. Representative images of RhoA (green) and nuclei (blue) of chondrocytes under basal ( C ) or inflammatory conditions ( D ). Control: untreated chondrocytes. Zoomed-in panels highlight the more intense RhoA staining in the cytoplasm. The white arrow in the “IL-1β” zoomed-in panel indicates the presence of RhoA in the cytoplasm. Scale bar 100 μm.

    Article Snippet: After three washes with PHEM-glycine buffer (PHEM containing 100 mM glycine), nuclei were stained with Hoechst 33342 (1/1000, Invitrogen #H3570) and secondary antibodies: Alexa Fluor 488 goat anti-mouse IgG (1:1000, Invitrogen #A11029, Carlsbad, CA, USA) or Alexa Fluor 647 goat anti-rabbit IgG (1:1000, Invitrogen #A21244, Carlsbad, CA, USA) for 1 h at room temperature.

    Techniques: Cell Culture, Incubation, Immunolabeling, Staining, Fluorescence, Control

    Effect of LOCBE, rLOPAP, and rLOSAC on β-catenin and Rab9. Chondrocytes (8 × 10 3 cells/well in 96-well plate) cultured in DMEM-F12 medium containing 1% FBS were treated or not with 1 ng/mL IL-1β for 1 h, followed by the addition of 50 µg/mL LOCBE, 200 nM rLOSAC, or 200 nM rLOPAP and incubation for 24 h. Cells were fixed and immunolabeled with a primary antibody against β-catenin and an Alexa Fluor-647-conjugated secondary antibody (red), and a primary antibody against Rab9 with an Alexa Fluor-488-conjugated secondary antibody (green), with nuclear counterstaining by Hoechst 33342 (blue). The stained samples were analyzed by HCS (20× magnification) for quantification of β-catenin ( A ) and Rab9 ( B ). Data represent the mean ± SD from 16 different fields per well. # p > 0.05, * p > 0.05, *** p > 0.001, **** p > 0.0001 (unpaired Student’s t -test, n = 3 independent replicates). CTRL, chondrocytes cultivated in basal DMEM-F12 medium containing 1% FBS (dotted line as a reference). Representative images of β-catenin (red), Rab9 (green), and nuclei (blue) in chondrocytes under basal ( C ), or inflammatory conditions ( D ). Control: untreated chondrocytes. The white arrows in the “rLOSAC” and “rLOPAP” panels highlight retracted and rounded cells, with yellow color indicating the internalization of β-catenin. In samples treated with rLOSAC and rLOPAP, β-catenin is more intense at the cell junctions. Scale bar 100 μm.

    Journal: International Journal of Molecular Sciences

    Article Title: Venom-Derived Proteins from Lonomia obliqua Modulate Cytoskeletal Regulators and Inflammatory Responses in Human Chondrocytes

    doi: 10.3390/ijms27020934

    Figure Lengend Snippet: Effect of LOCBE, rLOPAP, and rLOSAC on β-catenin and Rab9. Chondrocytes (8 × 10 3 cells/well in 96-well plate) cultured in DMEM-F12 medium containing 1% FBS were treated or not with 1 ng/mL IL-1β for 1 h, followed by the addition of 50 µg/mL LOCBE, 200 nM rLOSAC, or 200 nM rLOPAP and incubation for 24 h. Cells were fixed and immunolabeled with a primary antibody against β-catenin and an Alexa Fluor-647-conjugated secondary antibody (red), and a primary antibody against Rab9 with an Alexa Fluor-488-conjugated secondary antibody (green), with nuclear counterstaining by Hoechst 33342 (blue). The stained samples were analyzed by HCS (20× magnification) for quantification of β-catenin ( A ) and Rab9 ( B ). Data represent the mean ± SD from 16 different fields per well. # p > 0.05, * p > 0.05, *** p > 0.001, **** p > 0.0001 (unpaired Student’s t -test, n = 3 independent replicates). CTRL, chondrocytes cultivated in basal DMEM-F12 medium containing 1% FBS (dotted line as a reference). Representative images of β-catenin (red), Rab9 (green), and nuclei (blue) in chondrocytes under basal ( C ), or inflammatory conditions ( D ). Control: untreated chondrocytes. The white arrows in the “rLOSAC” and “rLOPAP” panels highlight retracted and rounded cells, with yellow color indicating the internalization of β-catenin. In samples treated with rLOSAC and rLOPAP, β-catenin is more intense at the cell junctions. Scale bar 100 μm.

    Article Snippet: After three washes with PHEM-glycine buffer (PHEM containing 100 mM glycine), nuclei were stained with Hoechst 33342 (1/1000, Invitrogen #H3570) and secondary antibodies: Alexa Fluor 488 goat anti-mouse IgG (1:1000, Invitrogen #A11029, Carlsbad, CA, USA) or Alexa Fluor 647 goat anti-rabbit IgG (1:1000, Invitrogen #A21244, Carlsbad, CA, USA) for 1 h at room temperature.

    Techniques: Cell Culture, Incubation, Immunolabeling, Staining, Control

    Increased sEV secretion in cholesterol‐depleted conditions is due to autophagy‐driven signalling. (A) Representative images for CD63 and LC3B expression in HEK293T or HEK293T ATG2A/B KO cells after vehicle, AY9944 or rapamycin and chloroquine (Rap & CQN) treatment. Scale bar, 25 µm. (B) Quantified CD63 expression in HEK293T and HEK293T ATG2A/B KO cells (mean ± SEM; n = 8 images analyzed from 2 independent experiments). Two‐way ANOVA (treatment effect: F2,42 = 47.99, p < 0.0001; Autophagy effect: F1,42 = 5.422, p ≤ 0.0248). Sidak's multiple comparisons test (** p ≤ 0.005, **** p < 0.0001). (C) LC3B expression in HEK293T and HEK293T ATG2A/B KO cells (mean ± SEM; n = 8, 4 images analyzed from 2 independent experiments). Two‐way ANOVA (interaction effect: F2,42 = 6.126, p ≤ 0.0046; treatment effect: F2,42 = 5.995, p ≤ 0.0051; Autophagy effect: F1,42 = 12.65, p ≤ 0.0009). Sidak's multiple comparisons test (* p ≤ 0.05, ** p ≤ 0.005, *** p ≤ 0.001). (D) Immunoblot for LC3B in isolated sEVs upon cholesterol depletion. (E) CD63 and LC3B colocalization in HEK293T and HEK293T ATG2A/B KO cells (mean ± SEM; n = 8 images analyzed from 2 independent experiments). Two‐way ANOVA (interaction effect: F2,53 = 128.9, p < 0.0001; treatment effect: F2,53 = 157.0, p < 0.0001; autophagy effect: F1,53 = 453.1, p < 0.0001). Sidak's multiple comparisons test (**** p < 0.0001). (F) Quantified sEV secretion in HEK293T or HEK293T ATG2A/B KO cells following vehicle, AY9944, or Rap & CQN treatments (mean ± SEM; n = 3 biological replicates from 3 independent experiments). One‐way ANOVA (F2,6 = 56.17, p ≤ 0.0001), Dunnett's multiple comparisons test (** p ≤ 0.01, **** p < 0.0001). (G) sEV secretion in HEK293T or HEK293T ATG2A/B KO cells following vehicle or D609 treatments (mean ± SEM; n = 3 biological replicates from 3 independent experiments). Unpaired t‐test (HEK293T: t4 = 9.395, *** p ≤ 0.0007; HEK293T ATG2A/B KO: t 4 = 4.069, ** p ≤ 0.0152).

    Journal: Journal of Extracellular Vesicles

    Article Title: Cholesterol Deficiency Directs Autophagy‐Dependent Secretion of Extracellular Vesicles

    doi: 10.1002/jev2.70218

    Figure Lengend Snippet: Increased sEV secretion in cholesterol‐depleted conditions is due to autophagy‐driven signalling. (A) Representative images for CD63 and LC3B expression in HEK293T or HEK293T ATG2A/B KO cells after vehicle, AY9944 or rapamycin and chloroquine (Rap & CQN) treatment. Scale bar, 25 µm. (B) Quantified CD63 expression in HEK293T and HEK293T ATG2A/B KO cells (mean ± SEM; n = 8 images analyzed from 2 independent experiments). Two‐way ANOVA (treatment effect: F2,42 = 47.99, p < 0.0001; Autophagy effect: F1,42 = 5.422, p ≤ 0.0248). Sidak's multiple comparisons test (** p ≤ 0.005, **** p < 0.0001). (C) LC3B expression in HEK293T and HEK293T ATG2A/B KO cells (mean ± SEM; n = 8, 4 images analyzed from 2 independent experiments). Two‐way ANOVA (interaction effect: F2,42 = 6.126, p ≤ 0.0046; treatment effect: F2,42 = 5.995, p ≤ 0.0051; Autophagy effect: F1,42 = 12.65, p ≤ 0.0009). Sidak's multiple comparisons test (* p ≤ 0.05, ** p ≤ 0.005, *** p ≤ 0.001). (D) Immunoblot for LC3B in isolated sEVs upon cholesterol depletion. (E) CD63 and LC3B colocalization in HEK293T and HEK293T ATG2A/B KO cells (mean ± SEM; n = 8 images analyzed from 2 independent experiments). Two‐way ANOVA (interaction effect: F2,53 = 128.9, p < 0.0001; treatment effect: F2,53 = 157.0, p < 0.0001; autophagy effect: F1,53 = 453.1, p < 0.0001). Sidak's multiple comparisons test (**** p < 0.0001). (F) Quantified sEV secretion in HEK293T or HEK293T ATG2A/B KO cells following vehicle, AY9944, or Rap & CQN treatments (mean ± SEM; n = 3 biological replicates from 3 independent experiments). One‐way ANOVA (F2,6 = 56.17, p ≤ 0.0001), Dunnett's multiple comparisons test (** p ≤ 0.01, **** p < 0.0001). (G) sEV secretion in HEK293T or HEK293T ATG2A/B KO cells following vehicle or D609 treatments (mean ± SEM; n = 3 biological replicates from 3 independent experiments). Unpaired t‐test (HEK293T: t4 = 9.395, *** p ≤ 0.0007; HEK293T ATG2A/B KO: t 4 = 4.069, ** p ≤ 0.0152).

    Article Snippet: For FBS rescue experiments, HEK293T cells were treated with vehicle, simvastatin or AY9944 for 24 h. Media was then replaced with 10% EV‐depleted FBS for 24 or 48 h. Other pharmacological agents utilized in these studies include rapamycin (1 μM, Selleck Chemicals; mTOR inhibitor), chloroquine (10 μM, Cayman Chemical; inhibits autophagosome‐lysosome fusion), D609 (100 μM, MedChemExpress; phosphatidyl choline phospholipase C inhibitor), and Q‐VD‐Oph (10 μM, Selleck Chemicals; pan‐caspase inhibitor).

    Techniques: Expressing, Western Blot, Isolation